Compare KOD & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KOD | HPP |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 795.5M | 648.9M |
| IPO Year | 2018 | 2010 |
| Metric | KOD | HPP |
|---|---|---|
| Price | $22.87 | $1.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 12 |
| Target Price | ★ $22.29 | $2.86 |
| AVG Volume (30 Days) | 774.9K | ★ 7.6M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $781,676,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.92 | $1.67 |
| 52 Week High | $23.63 | $3.96 |
| Indicator | KOD | HPP |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 42.13 |
| Support Level | $19.25 | $2.07 |
| Resistance Level | $23.63 | $2.45 |
| Average True Range (ATR) | 1.92 | 0.13 |
| MACD | 0.24 | 0.01 |
| Stochastic Oscillator | 89.70 | 50.83 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.